lapatinib has been researched along with azelastine in 1 studies
| Studies (lapatinib) | Trials (lapatinib) | Recent Studies (post-2010) (lapatinib) | Studies (azelastine) | Trials (azelastine) | Recent Studies (post-2010) (azelastine) |
|---|---|---|---|---|---|
| 1,919 | 305 | 1,442 | 564 | 160 | 112 |
| Protein | Taxonomy | lapatinib (IC50) | azelastine (IC50) |
|---|---|---|---|
| Cytochrome P450 2D6 | Homo sapiens (human) | 1 | |
| Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 6.3096 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 0.1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, KS; Cabeza de Vaca, I; Deshmukh, M; Ghahremanpour, MM; Ippolito, JA; Jorgensen, WL; Liosi, ME; Tirado-Rives, J; Zhang, CH | 1 |
1 other study(ies) available for lapatinib and azelastine
| Article | Year |
|---|---|
Identification of 14 Known Drugs as Inhibitors of the Main Protease of SARS-CoV-2.
Topics: | 2020 |